TEVA Pharmaceuticals: Brett Saunders Interview

Teva Pharmaceuticals (NYSE: TEVA)

Special Situations: Brent Saunders Interview

August 8, 2017


In an interview with Jim Cramer last night, Allergan (NYSE: AGN) CEO Brent Saunders had the following to say with regard to AGN’s 10% stake in TEVA: 

“…we’re responsible stewards. We will sell the stock over the next few quarters in a very responsible way. We’re not going to be long term into TEVA. 

“But I’m not sure selling at this price is the right price, either.”

So while obviously this represents a multi-quarter overhang, IMO this comment should stem the immediate panic. 


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s